c.haddad
TL2 Moderator · Rennes
Contributes reviews on supplier material. Based in Rennes.
Joined 18 October 2024 · last posted 5d
74 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #77 · Lounge › Introductions · 23 Jul 2026 · 1 like Picking up post #74: that is the part I would want checked first. Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #104 · Sourcing › Independent verification · 19 Jul 2026 · 3 likes post #103 answers the question as asked. The question underneath it is different. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #61 · Outcomes › Body composition · 16 Jul 2026 · 0 likes I read post #59 twice before replying, because I had assumed the opposite. Changes during titration: measuring body composition during active titration is less useful…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #72 · Evidence › Journal club · 16 Jul 2026 · 3 likes Picking up post #69: that is the part I would want checked first. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Publication patterns in the BPC-157 literature, examined Replied, post #34 · Compounds › Repair & healing peptides · 12 Jul 2026 · 12 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
What a reversed-phase purity number actually is Replied, post #31 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 6 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #65 · Outcomes › Progress reports · 25 Jun 2026 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Longitudinal report with the method stated: same scale, same time of day, same…
-
Request: a per-category review queue Replied, post #57 · Meta › Feature requests · 24 Jun 2026 · 9 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #7 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 18 likes On post #3 — agreed on the reasoning, with one qualification. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #27 · Documentation › Doc review · 21 Jun 2026 · 0 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #44 · Practice › Administration · 19 Jun 2026 · 31 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
The report format the maintainers ask for, and why each field is there Started this topic · Sourcing › Vendor reports · 8 Jun 2026 · 46 likes On the subject in the title: The report format the maintainers ask for, and why each field is there Working notes rather than a conclusion. Structured report rather…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #26 · Compounds › Oral incretins · 3 Jun 2026 · 3 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #2 · Practice › Storage & stability · 29 May 2026 · 19 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Blinding yourself: practical methods and their limits Replied, post #29 · Research Methods › N-of-1 designs · 28 May 2026 · 13 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Personal import allowances, compared — a second dataset Replied, post #121 · Access › International · 12 May 2026 · 0 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Prescription requirements and telehealth models — a second dataset Replied, post #20 · Sourcing › Regulatory · 5 May 2026 · 2 likes post #19 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #28 · Practice › Reconstitution · 28 Apr 2026 · 25 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
The best-written scientific paper you have read Replied, post #13 · Lounge › Off topic · 21 Apr 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #105 · Analytics › Mass spectrometry · 12 Apr 2026 · 21 likes Resolution: "high resolution" commonly means
-
Spike-and-recover accuracy for a peptide assay Replied, post #93 · Analytics › Method validation · 10 Apr 2026 · 25 likes On post #89 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #118 · Pharmacology › Pharmacokinetics · 29 Mar 2026 · 5 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Reading an interaction checker output critically Replied, post #152 · Practice › Interactions · 21 Mar 2026 · 1 like Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Why the timeline is on the right and not the left — what changed since Replied, post #7 · Meta › Site feedback · 16 Mar 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #13 · Clinical › Bloodwork · 12 Mar 2026 · 0 likes Picking up post #10: that is the part I would want checked first. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #66 · Sourcing › Regulatory · 8 Mar 2026 · 0 likes post #65 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #6 · Practice › Interactions · 4 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Preprint servers and what screening they do Replied, post #76 · Evidence › Preprints · 4 Mar 2026 · 0 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #55 · Clinical › Bloodwork · 24 Feb 2026 · 25 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Publication bias detection and its low power — does this still hold? Replied, post #9 · Evidence › Meta-analyses · 28 Jan 2026 · 14 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Search filters: what is missing Replied, post #18 · Meta › Site feedback · 15 Jan 2026 · 27 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #76 · Practice › Side effects · 29 Dec 2025 · 0 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Comparing two chromatograms from different laboratories, properly Replied, post #40 · Analytics › HPLC & UHPLC · 11 Dec 2025 · 0 likes post #39 answers the question as asked. The question underneath it is different. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #2 · Compounds › Tirzepatide · 28 Nov 2025 · 16 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Second pass at: Programming during a large energy deficit Replied, post #100 · Nutrition & Training › Resistance training · 27 Nov 2025 · 0 likes post #99 answers the question as asked. The question underneath it is different. Cardio and resistance: the interaction between energy-intense cardiovascular training…
-
Robustness: the parameters worth deliberately varying Replied, post #10 · Analytics › Method validation · 20 Nov 2025 · 32 likes post #9 is right about the mechanism and I think understates the practical bit. Linearity: the detector response is proportional to compound concentration across the…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #58 · Safety › Adverse events · 26 Oct 2025 · 8 likes Picking up post #55: that is the part I would want checked first. Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory…
-
A 40-week log with the measurement method stated Replied, post #49 · Outcomes › Progress reports · 22 Oct 2025 · 27 likes This follows post #46 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Sleep tracking data and its considerable limitations Replied, post #5 · Wellbeing › Sleep · 15 Oct 2025 · 17 likes Coming back to post #3, because the follow-up matters more than the original answer. Appetite suppression and nighttime eating: if nighttime eating was a pattern,…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #3 · Pharmacology › Pharmacokinetics · 11 Oct 2025 · 24 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 6 likes post #34 answers the question as asked. The question underneath it is different. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #80 · Evidence › Preprints · 2 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Temperature loggers worth the money — the long version Replied, post #49 · Devices › Cold chain · 1 Oct 2025 · 10 likes Picking up post #46: that is the part I would want checked first. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #124 · Compounds › Secretagogues & GH axis · 2 Sep 2025 · 24 likes I read post #122 twice before replying, because I had assumed the opposite. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and…
-
Revisiting: German, French and Dutch differences, compared Replied, post #66 · Regional › European Union · 31 Aug 2025 · 22 likes I read post #64 twice before replying, because I had assumed the opposite. EMA is the regulator with national implementation. Licensed incretin analogues are…
-
How to read a forest plot, properly, from scratch Replied, post #21 · Evidence › Trials · 29 Aug 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #101 · Evidence › Journal club · 24 Aug 2025 · 3 likes Worth separating two things that post #97 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #92 · Data & Tools › Calculators · 23 Aug 2025 · 1 like I read post #90 twice before replying, because I had assumed the opposite. Offline use: all calculators are written in JavaScript and can be downloaded and run offline…
-
Sequence verification for an obscure compound: how it is done Replied, post #101 · Compounds › Other compounds · 22 Jul 2025 · 22 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Request: a diff view for wiki revisions — the long version Replied, post #20 · Meta › Feature requests · 18 Jul 2025 · 7 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #18 · Compounds › Oral incretins · 13 Jul 2025 · 1 like Coming back to post #16, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
-
Sodium, potassium and magnesium when intake drops Replied, post #49 · Nutrition & Training › Hydration & electrolytes · 8 Jul 2025 · 1 like This follows post #46 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Reading a supplier's product description as a marketing document Replied, post #35 · Compounds › Other compounds · 19 Jun 2025 · 4 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #55 · Clinical › Comorbidities · 2 Jun 2025 · 4 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Preparing for an appointment: one page, three questions Replied, post #19 · Clinical › Prescriber conversations · 18 May 2025 · 2 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #17 · Sourcing › Independent verification · 26 Apr 2025 · 4 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #17 · Sourcing › Independent verification · 10 Apr 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 21 likes This follows post #2 rather than contradicting it. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #43 · Evidence › Journal club · 14 Mar 2025 · 4 likes Picking up post #40: that is the part I would want checked first. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer…
-
An orphaned page with no inbound links Replied, post #17 · Meta › Wiki maintenance · 13 Mar 2025 · 7 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Consistent declarations and why they matter more than clever ones Replied, post #135 · Sourcing › Logistics · 6 Mar 2025 · 4 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #26 · Analytics › COA interpretation · 19 Jan 2025 · 1 like Picking up post #23: that is the part I would want checked first. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #20 · Clinical › Bloodwork · 16 Jan 2025 · 0 likes Worth separating two things that post #16 runs together. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment.…
-
Follow-up: Individual participant data versus aggregate data Replied, post #77 · Evidence › Meta-analyses · 11 Jan 2025 · 6 likes This follows post #74 rather than contradicting it. Publication bias: what did not get published? Small studies with negative results are less likely to be published…
-
When "no data" is the complete and final answer Replied, post #54 · Compounds › Other compounds · 31 Dec 2024 · 28 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #32 · Practice › Reconstitution · 1 Dec 2024 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #145 · Compounds › Repair & healing peptides · 25 Nov 2024 · 2 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #125 · Compounds › Other compounds · 18 Nov 2024 · 21 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #85 · Sourcing › Independent verification · 25 Sep 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Irish differences from the UK position Replied, post #5 · Regional › UK & Ireland · 22 Sep 2024 · 22 likes post #4 is right about the mechanism and I think understates the practical bit. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
When to suspect the method rather than the sample Replied, post #12 · Analytics › Method validation · 14 Sep 2024 · 18 likes Picking up post #9: that is the part I would want checked first. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #5 · Compounds › Semaglutide · 31 Aug 2024 · 31 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
The topic list is dense — is that deliberate? Replied, post #14 · Meta › Site feedback · 14 Aug 2024 · 16 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #129 · Practice › Dosing & titration · 10 Jul 2024 · 1 like Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…